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A B S T R A C T
The complete mechanism accounting for the progression from simple steatosis to steatohepatitis in nonalcoholic
fatty liver disease (NAFLD) has not been elucidated. Lipotoxicity refers to cellular injury caused by hepatic free
fatty acids (FFAs) and cholesterol accumulation. Excess cholesterol autoxidizes to oxysterols during oxidative
stress conditions. We hypothesize that interaction of FAs and cholesterol derivatives may primarily impair
mitochondrial function and affect biogenesis adaptation during NAFLD progression. We demonstrated that the
accumulation of specific non-enzymatic oxysterols in the liver of animals fed high-fat+high-cholesterol diet
induces mitochondrial damage and depletion of proteins of the respiratory chain complexes. When tested in vitro,
5α-cholestane-3β,5,6β-triol (triol) combined to FFAs was able to reduce respiration in isolated liver mi-
tochondria, induced apoptosis in primary hepatocytes, and down-regulated transcription factors involved in
mitochondrial biogenesis. Finally, a lower protein content in the mitochondrial respiratory chain complexes was
observed in human non-alcoholic steatohepatitis. In conclusion, hepatic accumulation of FFAs and non-enzy-
matic oxysterols synergistically facilitates development and progression of NAFLD by impairing mitochondrial
function, energy balance and biogenesis adaptation to chronic injury.
1. Introduction
Nonalcoholic fatty liver disease (NAFLD), the most common liver
pathology in the Western world [1], may clinically present with a
heterogeneity of conditions ranging from benign steatosis (NAFL) to
steatohepatitis (NASH) – the more progressive form of the disease [2] –
and to cirrhosis. The mechanisms underlying the transformation from
non inflamed to inflamed fatty liver are not completely elucidated, even
though lipid metabolism alterations, mitochondrial dysfunction, in-
flammation and oxidative stress are suggested to play a significant role
[3–6].
Accumulating lipids in hepatocytes may be vulnerable to free ra-
dical-induced peroxidation. Lipid peroxides exert toxic effects on the
mitochondrial DNA (mtDNA), RNA and proteins of the respiratory
chain, leading to mitochondrial dysfunction [7].
Lipotoxicity refers to cellular injury caused by excess of free fatty
acids (FFAs) and related-lipid metabolites [8]. Excess cholesterol can
lead to dysregulation of cholesterol metabolism, which is considered an
underlying pathology in the development of many metabolic diseases
[9]. Loading mitochondria with free cholesterol sensitizes hepatic cells
to inflammatory mediators such as Tumor Necrosis Factor (TNF) and
cell-surface Fas receptor (Fas), which may precipitate steatohepatitis
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[10]. Free cholesterol accumulation in oxidative settings may promote
its oxidization with final production of oxysterols that are involved in
NAFLD damage [11,12]. Dietary fat and cholesterol induce the meta-
bolic and hepatic features of NASH in mice only when acting sy-
nergistically but not when administered alone [13]. We have previously
shown that the significant change in fatty acid and oxysterols profile
induced by a dietary combination of high fat and high cholesterol ac-
counts for liver injury, allowing the generation of interesting hy-
potheses on the role of interaction of lipid and cholesterol metabolites
in the pathogenesis of NAFLD progression [14].
In the present study, after a lipidomic analysis of hepatic non-en-
zymatic oxysterols in animals fed high-fat or high-fat+high-cholesterol
diet, we analyzed mitochondrial function, biogenesis and mitochondrial
respiratory chain proteins, and we demonstrated a significant impair-
ment in the respiratory chain and energy homeostasis secondary to
depletion of specific respiratory chain complexes. The analysis of mi-
tochondrial biogenesis signaling revealed that FFAs and non-enzymatic
oxysterols synergistically interact and limit the adaptive response of
liver cells to chronic lipid accumulation, promoting transition from
steatosis to steatohepatitis. The observations were then confirmed in
human NASH.
2. Materials and methods
Further details are provided in the Supporting Information.
Fig. 1. Increased non-enzymatic oxysterol levels in the liver
of HF+HCh-induced NASH. (A) Histological analysis of re-
presentative liver samples from rats fed a standard (CTRL), high-
fat (HF) or high-fat+high-cholesterol (HF+HCh) diet, stained
with Haematoxilin & Eosin (magnification 100x and 200x). (B)
Serum levels of aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) in all the animal groups studied. (C)
Hepatic levels of the non-enzymatic oxysterols measured by mass
spectrometry in all the groups studied. Data are expressed as
mean± SDM of five consecutive experiments. Statistical differ-
ences were assessed by one-way ANOVA and Tukey-Kramer as
post-hoc test (* = p<0.05 vs CTRL; ** = p<0.01 vs CTRL; ^ =
p<0.05 vs HF; ^^ = p<0.01 vs HF). 7 beta, 7β-hydro-
xycholesterol; 5b,6b-epoxy, 5β,6β-epoxycholesterol; 5a,6a-epoxy,
5α,6α-epoxycholesterol; triol, 5α-cholestane-3β,5,6β-triol; 7-
keto, 7-ketocholesterol; 6-oxo, 6-oxo-cholestan-3β,5α-diol.
Table 1
Kleiner scoring system applied to liver samples from rats fed a standard (CTRL), high-fat
(HF) or high-fat+high-cholesterol (HF+HC) diet.
Steatosis Ballooning Lobular
Inflammation
Activity
Score
Indication
CTRL 0 0 0 0 Normal
HF 3 0 1 4 NAFL
HF+HCh 2 2 2 6 NASH
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2.1. Animals and experimental design
Male Wistar rats (Harlan, San Pietro al Natisone, Italy) were divided
into the following 3 groups: CTRL, control rats given a standard chow;
HF, rats given a high-fat diet (60% cocoa butter); HF+HCh, rats fed a
high-fat and high-cholesterol diet (60% cocoa butter + 1.25% choles-
terol). The compositions of the diets has been previously shown in [15].
2.1.1. Human study
Liver specimens were obtained during non-hepatic abdominal sur-
gery from 18 consecutive patients (10 NASH and 8 steatosis, according
to liver histology) and 8 healthy subjects undergoing laparoscopic
cholecystectomy. All subjects included in the study were negative for
viral hepatitis infection, liver autoimmune or metabolic disorders and
were not under treatment with hepatotoxic drugs. All patients gave
written informed consent to the study, which was conducted according
to the Declaration of Helsinki.
2.1.2. Oxysterols measurement
For cholesterol oxidation markers, we measured in liver samples the
oxysterols generated via a free radical–mediated mechanism (7β-hy-
droxycholesterol, 7β-OHC; 5β,6β-epoxycholesterol, 5β,6β-epoxy;
5α,6α-epoxycholesterol, 5α,6α-epoxy; 5α-cholestane-3β,5,6β-triol,
triol; 7-ketocholesterol, 7KC; 6-oxo-cholestan-3β,5α-diol, 6-oxo) by
mass spectrometry with isotope-dilution methods, as previously re-
ported [14].
2.1.3. Rat hepatocytes isolation, culture and treatment
Hepatocytes were isolated from non-treated animals using a mod-
ified collagenase perfusion technique as described previously [16].
Cells were treated for 24 h with 7β-OHC, 7-KC or triol to give a final
concentration of 10−6, 10−5, 10−4, and 10−3 M. 7β-OHC, 7-KC and
Triol were dissolved in ethanol for delivery to cells and the final con-
centration of ethanol in the cultures did not exceed 0.1% (v/v).
Equivalent quantities of ethanol were added to control cells. The
treatment with oxysterols was also performed in the presence of pal-
mitic (PA) or oleic acid (OA), at titrated concentrations. Cellular sur-
vival was determined by the microculture tetrazolium assay [17], while
apoptosis was analyzed using the annexin V-fluorescein isothiocyanate
apoptosis detection kit (Beckman Coulter, Milan, Italy).
2.1.4. Oxygraphic measurements
Respiratory rates were measured in isolated hepatocytes as de-
scribed [18]. Freshly prepared liver mitochondria were assayed for
oxygen consumption as previously reported [19]. Mitochondrial
membrane potential (Δψ) and proton leak analysis were measured as
previously reported [19].
2.1.5. Evaluation of FOF1ATPase activity and tissue ATP content
FOF1ATPase activity was measured following ATP hydrolysis with
an ATP-regenerating system coupled to NADPH oxidation [20]. The
hepatic ATP concentration was assessed by bioluminescence (Enliten
ATP assay kit - Promega Corporation, Madison, WI, USA) according to
the method of Yang [21].
2.1.6. Measurement of mitochondrial H2O2 production
The rate of peroxide production was determined in isolated liver
mitochondria following the oxidation of Amplex Red by horseradish
peroxidase as previously reported [19].
2.1.7. q-PCR array of mitochondrial energy metabolism – related genes
20 ng cDNA was loaded into each well in RT2 Profiler 96-well PCR
array plates (PARN-008Z, QIAGEN, Valencia CA). The median cycle
threshold value (CT) was uploaded onto the SABioscience website
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php) and
the fold change of each gene expression was calculated using the pro-
vided software according to manufacturer's instruction.
2.1.8. Gene expression analysis by real-time RT-PCR
Real-time RT-PCR was performed on RNA extracted from human
liver tissue or rat primary hepatocytes, using SYBR Green I assay in Bio-
Rad iCycler detection system as previously reported [19]. A PCR master
mix containing the specific primers shown in Supplementary Table 1
was used. The threshold cycle (CT) was determined, and the relative
gene expression subsequently was calculated as follows: fold change =
2−Δ(ΔCT), where ΔCT = CT − CT target housekeeping and Δ(ΔCT) =
ΔCT – ΔCT treated control.
2.1.9. Blue Native bidimensional polyacrylamide gel electrophoresis (BN-
PAGE)
BN-PAGE was performed on human liver mitochondria proteins as
described [22]. First, solubilized samples were stained with a charged
(Coomassie) dye. The intact mitochondrial complexes were then sepa-
rated by electrophoresis based upon how much dye was bound, which is
proportional to their size. After this first dimension gel, which was run
in a 5–12% acrylamide gradient, a lane was cut out and placed on a
glass plate for incubation with lysis buffer at room temperature. The
protein components of the resolved complexes were separated in a
second dimension after soaking the gel in denaturing SDS buffer. For
the detection of all five OXPHOS complexes simultaneously a mix of
monoclonal antibodies was used (MitoScience MS603 kit, AbCam,
Oregon, USA).
2.1.10. Statistical analysis
The data were normally distributed and were expressed as
mean± standard deviation of the mean (SDM). Differences between
the groups were determined by one-way analysis of variance (ANOVA)
with Tukey-Kramer as post hoc test. Statistical significance was accepted
when P<0.05. The GraphPad Prism 6.0 Software was used to perform
the analysis.
3. Results
3.1. Combination diet (HF+HCh) increases non-enzymatic oxysterol level
in NASH liver
Rats fed high-fat diet (HF) for 6 weeks showed severe liver steatosis
Table 2
Respiratory activity, Respiratory Control Index (RCI) and Membrane Potential (MMP) in
isolated liver mitochondria from rats fed the standard (CTRL), high-fat (HF) or high-fat
+high-cholesterol (HF+HC) diets for 6 weeks. Data are expressed as mean± SDM of five
consecutive experiments. Statistical differences were assessed by one-way ANOVA and
Tukey-Kramer as post-hoc test (* = p<0.05 vs CTRL, ^ = p<0.05 vs HF).
CTRL HF HF+HCh
Complex I
State 4 (nmolO2/
min/mg)
2.5± 0.6 4.1± 1.3 4.4± 3.9
State 3 (nmolO2/
min/mg)
13.5± 2.3 13.3± 4.1 9.2±5.6*
RCI 5.5± 0.4 3.9± 0.8 2.5±2.2*
Uncoupled/State 3 0.8± 0.1 1.0± 0.1 1.0± 0.1
Complex II
State 4 (nmolO2/
min/mg)
14.3± 7.1 20.2± 3.9 41.4±22.6*,^
State 3 (nmolO2/
min/mg)
31.8± 16.3 40.1± 11.4 68.8±23.7*
RCI 2.2± 0.1 2.0± 0.7 1.77± 0.30
Uncoupled/State 3 1.2± 0.2 1.2± 1.0 1.4± 0.1
Complex IV
State 4 (nmolO2/
min/mg)
59.3± 24.6 40.8± 10.8 78.9± 36.1
Uncoupled State
(nmolO2/min/mg)
85.2± 30.4 80.3± 15.8 99.3± 34.8
MMP (mV) 172±2 156±3* 149±6*
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but mild lobular inflammation; on the other hand, animals fed the high-
fat+high-cholesterol diet (HF+HCh) exhibited a severe liver damage
characterized by macrovesicular steatosis, hepatocytes ballooning and
diffused lobular infiltration, as well as increased serum amino-
transferase levels, suggestive of NASH (Fig. 1A and B, Table 1).
The lipidomic analysis of non-enzymatic oxysterols in rat liver re-
vealed a significant increase of 7β-hydroxycholesterol (7β-OHC), 7-
ketocholesterol (7-KC) and 5α-cholestane-3β,5,6β-triol (Triol) in the HF
+HCh livers, as compared to the CTRL and HF groups (Fig. 1C).
3.2. Mitochondrial function, ATP homeostasis and biogenesis are severely
impaired in livers feeding HF and HC combination diet
Freshly isolated mitochondria were analyzed in terms of oxygen
consumption rate, mitochondrial membrane potential (MMP), hy-
drogen peroxide production rate, ATP homeostasis and proton leak
kinetics.
Oxygen uptake was impaired by the mitochondrial Complex I (while
it was enhanced by the Complex II) in the HF+HCh group as compared
to CTRL rats; however, MMP was reduced both in the HF and in the HF
+HCh group (Table 2).
We then analyzed the hepatic ATP homeostasis and observed that
both diets induced a reduction in the liver ATP content when compared
to CTRL (Fig. 2A). To determine whether the reduction of ATP was
dependent on an impairment in mitochondrial ATP synthesis, the en-
zymatic activity of Complex V (ATP-synthase) was measured and we
observed a severe reduction in animals fed the HF+HCh but not the HF
diet (Fig. 2B).
The dissipation of MMP through the mitochondrial membranes
(proton leak) is a well-established hallmark of mitochondrial dysfunc-
tion in NAFLD [23]. Mitochondria proton leak was observed in both the
HF and the HF+HCh livers as compared to CTRL (Fig. 3A), and was
associated with increased Uncoupling Protein 2 (UCP2) expression
(Fig. 3B-D).
Impaired mitochondria produce free radicals, which were quanti-
fied by measuring the hydrogen peroxide (H2O2) production rate using
pyruvate/malate or succinate as mitochondrial substrates. The rate of
H2O2 synthesis was not changed in the HF group with respect to CTRL;
Fig. 2. Hepatic ATP homeostasis and mitochondrial H2O2
production rate impairment in HF+HCh-induced NASH. (A)
Hepatic ATP content in rats fed a standard (CTRL), high-fat (HF)
or high-fat+high-cholesterol (HF+HCh) diet for 6 weeks. (B)
Complex V (ATPase) activity in all the groups studied. (C) hy-
drogen peroxide production rate in liver mitochondria from all
the groups studied, using glutamate + malate (Complex I) or
succinate in the presence of rotenone (Complex II) as oxidative
substrates. Data are expressed as mean± SDM of five consecutive
experiments. Statistical differences were assessed by one-way
ANOVA and Tukey-Kramer as post-hoc test. (* = p<0.05 vs
CTRL; ** = p<0.01 vs CTRL; ^ = p<0.05 vs HF; ^^ = p<0.01
vs HF).
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on the contrast, the HF+HCh group showed a higher rate of mi-
tochondrial ROS production (Fig. 2C).
Taken together, these data show that the addition of cholesterol to a
high fat diet induces a significant change in the non-enzymatic oxy-
sterol profile that in turn induces a severe hepatic impairment of mi-
tochondrial function.
A Mitochondrial Energy Metabolism PCR Array was used to de-
termine the expression profile of 84 key genes involved in mitochon-
drial respiration, including those encoding components of the electron
transport chain and oxidative phosphorylation complexes.
As shown in Table 3A, the HF group presented the up-regulation of
Cox15, Bcs1L and Atp4a genes as compared to CTRL. On the contrast,
several genes encoding for subunits of mitochondrial Complex I, IV and
V were down-regulated in the HF+HCh (Table 3B), suggesting a severe
reduction of respiratory chain proteins.
3.3. Non-enzymatic oxysterols synergistically interact with FFAs and impair
mitochondrial function and biogenesis in vitro
To study a possible synergistic interaction between specific oxy-
sterols and fatty acids in the induction of liver injury, different com-
binations of free fatty acids with 7β-OHC, 7-KC or triol were tested in
vitro. Rat primary hepatocytes were incubated with 50 µM palmitic acid
(PA) as saturated fatty acid, and 2 mM oleic acid (OA) as unsaturated
fatty acid for 24 h. The addition of Triol to PA/OA significantly reduced
the viability of the primary hepatocytes at concentrations of 10 or
100 µM (Fig. 4A); however, the same concentration of 7β-OHC or 7-KC
did not induce any significant effect (supplementary material, Fig. S3A
and B). By flow cytometry we verified that the combination of the
lowest concentration of Triol (10 µM) + PA/OA induced hepatocellular
necrosis (7-AAD positive cells) rather than apoptosis (annexin V-stained
cells), while minimal effects were observed using Triol or PA/OA alone
(Fig. 4B).
The effects of 7β-OHC, 7-KC and triol were also tested on the
Fig. 3. Increased mitochondrial uncoupling and UCP2 ex-
pression in NAFLD. (A) Proton leak kinetics in mitochondria
isolated from rats fed a standard (CTRL), high-fat (HF) or high-fat
+high-cholesterol (HF+HCh) diet for 6 weeks. The membrane
potential dependence of the proton leak rate was determined in
mitochondria oxidizing succinate (10 mM) in the presence of ro-
tenone. Oligomycin was added to inhibit ATP synthase activity.
The small figures show the proton permeability obtained after
mitochondrial pre-incubation with the uncoupling proteins’inhi-
bitor guanosine diposphate (GDP). The proton permeability was
prevented by GDP in HF+HCh, but not in HF. (B) Gene expres-
sion of the Uncoupling Protein 2 (UCP2) measured by real time rt-
PCR in the liver of all groups studied. (C) and (D) Densitometric
analysis and representative blot of UCP2 immunoprecipitated in
liver mitochondria proteins from all the groups studied. Data are
expressed as mean± SDM of five consecutive experiments.
Statistical differences were assessed by one-way ANOVA and
Tukey-Kramer as post-hoc test.
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mitochondrial bioenergetics; to this, the oxygen consumption was
measured on both isolated liver mitochondria and intact primary he-
patocytes. No toxic effect was observed with 7β-OHC or 7-KC (sup-
plementary material, Fig. S4); on the contrary, a dose-dependent re-
duction of mitochondrial respiration was reported with Triol (Fig. 5A-
C). These data suggest that the combination of Triol + PA/OA induced
hepatocyte toxicity via mitochondrial bioenergetics impairment.
Peroxisome proliferator-activated receptor-γ coactivator 1 α
(PGC1α) and its downstream targets, mitochondrial transcription factor
A (TFAM) and nuclear respiratory factor 1 (NRF1) are the master reg-
ulator of mitochondrial biogenesis.
Interestingly, we observed that incubation of primary hepatocytes
with PA + OA in the presence of triol – but not of 7β-OHC or 7-KC –
significantly induced down-regulation of PGC1α, TFAM and NRF1,
suggesting a causative role for the combination of free fatty acids and
Triol in the mitochondrial biogenesis failure and in mitochondrial
dysfunction (Fig. 5D).
3.4. Mitochondrial biogenesis is impaired in NASH patients as compared to
simple steatosis and healthy livers
The characteristics of studied population are summarized in the
Table S2. NASH showed higher fasting serum triglycerides and cho-
lesterol as compared to healthy and steatosis subjects. Freshly isolated
mitochondria from human liver specimens were analyzed by 2D
electrophoresis and a reduction of proteins related to Complex I,
Complex IV and Complex V was observed only in NASH (Fig. 6A) but
not in simple steatosis. We then measured the mRNA expression of
master regulators of mitochondrial biogenesis and, very interestingly,
we observed a 50% reduction in the expression of PGC-1α in NASH
livers together with a slight reduction of TFAM and NRF1 (Fig. 6B).
These data suggest that, in humans, during NASH development, a mi-
tochondrial reduction of respiratory chain proteins occurs that is not
counterbalanced by activation of mitochondrial biogenesis response.
4. Discussion
The pathogenesis of NAFLD is mostly unclear. Clinicians are daily
faced with the difficulty to identify patients progressing from simple
steatosis to steatohepatitis, who present with a worse prognosis [24].
One of the burning questions in NAFLD remains which factors act as the
driving forces toward a progressive inflammatory disease phenotype.
Mitochondrial dysfunction has been suggested to play a significant role
in the progression of NAFLD [23]. The present study provides a new
insight on the mechanism by which free fatty acids and oxysterols in-
teract and induce NAFLD development and progression through the
impairment of mitochondrial function and biogenesis response to
chronic liver injury.
The accumulation of toxic lipids causes inflammation in the setting
of liver steatosis [25]. Several studies focused on triglyceride
Table 3
List of the genes up- or down-regulated (> 2 fold) in the HF (A) and HF+HC (B) groups with respect to CTRL. Changes in gene expression between groups were evaluated using RT2
Profiler 96-well PCR array plates. Data analysis was done by the 2-DDCt method on the manufacturer's Web portal (http://www.SABiosciences.com/pcrarraydataanalysis.php), (QIAGEN,
CA, USA).
RefSeq Symbol Description Fold Change
A
NM_001033699 Cox15 Cytochrome c oxidase assembly protein (yeast) 2,1936
NM_01007666 Bcs1l BCS1-like (yeast) 4
NM_012509 Atp4a ATPase, H+/K+ exchanging, alpha polypeptide 2,1936
B
NM_133517 Atp12a ATPase, H+/K+ transporting, alpha polypeptide −3,4983
NM_012510 Atp4b ATPase, H+/K+ exchanging, beta polypeptide −3,4983
NM_023093 Atp5a1 ATP synthase, mitochondrial F1 complex, alpha subunit 1 −2,0093
NM_134364 Atp5b ATP synthase, mitochondrial F1 complex, beta polypeptide −2,4172
NM_053825 Atp5c1 ATP synthase, mitochondrial F1 complex, gamma polypeptide 1 −2,1535
NM_080481 Atp5i ATP synthase, mitochondrial F0 complex, subunit e −3,4983
NM_053602 Atp5j ATP synthase, mitochondrial F0 complex, subunit F6 −2,1043
NM_212516 Atp5l ATP synthase, mitochondrial F0 complex, subunit G −2,0093
NM_031785 Atp6ap1 ATPase, H+ transporting, lysosomal accessory protein 1 −2,1535
NM_001014199 Atp6v1c2 ATPase, lysosomal V1 subunit C2 −3,4983
NM_001108979 Atp6v1e2 ATPase, lysosomal V1 subunit E2 −3,4983
NM_01007666 Bcs1l BCS1-like (yeast) −2,1043
NM_017202 Cox4i1 Cytochrome c oxidase subunit IV isoform 1 −2,4172
NM_145783 Cox5a Cytochrome c oxidase, subunit Va −2,1043
NM_012812 Cox6a2 Cytochrome c oxidase subunit VIa polypeptide 2 −3,4184
NM_019360 Cox6c Cytochrome c oxidase, subunit Vic −3,1895
NM_022503 Cox7a2 Cytochrome c oxidase subunit VIIa polypeptide 2 −2,2038
NM_182819 Cox7b Cytochrome c oxidase subunit VIIb −2,1535
NM_183055 Cox8c Cytochrome c oxidase, subunit VIIIc −3,4983
NM_001009706 Lhpp Phospholys phosphohistidine inorganic pyrophosp phosphatase −4,9474
NM_001108813 Ndufa1 NADH dehydrogenase 1 alpha subcomplex, 1 −3,0455
NM_212517 Ndufa11 NADH dehydrogenase 1 alpha subcomplex 11 −2,0562
NM_001106153 Ndufa2 NADH dehydrogenase 1 alpha subcomplex, 2 −2308
NM_001106646 Ndufb6 NADH dehydrogenase 1 beta subcomplex, 6 −2,0093
NM_001108442 Ndufb7 NADH dehydrogenase 1 beta subcomplex, 7 −2,2553
NM_001127294 Ndufb9 NADH dehydrogenase 1 beta subcomplex, 9 −2,5907
NM_001011907 Ndufs2 NADH dehydrogenase Fe-S protein 2 −3,1895
NM_001106489 Ndufs3 NADH dehydrogenase Fe-S protein 3 −2,2038
NM_001100539 Sdhb Succinate dehydrogenase complex, subunit B, iron sulfur −2,2553
NM_198788 Sdhd Succinate dehydrogenase complex, subunit D −2,0093
NM_133418 Slc25a10 Solute carrier family 25, member 10 −2,2553
NM_001047880 Slc25a15 Solute carrier family 25, member 15 −3,3404
NM_012682 Ucp1 Uncoupling protein 1 −3,4983
NM_013167 Ucp3 Uncoupling protein 3 −3,4983
NM_001025134 Uqcrq Ubiquinol-cytochrome c reductase, complex III subunit VII −3,4983
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accumulation as pathogenic factor [26,27]. Nevertheless, triglyceride
storage may protect liver cells from fatty acid-induced apoptotic path-
ways [28], and blocking triglyceride synthesis leads to less steatosis but
more inflammation, oxidative stress and fibrosis [29]. Even though the
type of hepatotoxic lipid has not been identified yet, both free fatty
acids and cholesterol, especially when accumulated in mitochondria,
could lead to liver injury and hepatocellular damage [10,30]. It has
been recently demonstrated that administration of peroxidized fatty
acids produces a dramatic inflammatory increase into the liver [31].
However, a lipidomic analysis on humans demonstrated that – more
than free fatty acids – free cholesterol accumulates in NAFLD [32].
Cholesterol is essential for proper cell function; however, free
cholesterol accumulation in an oxidative milieu may promote its oxi-
dization with final production of oxysterols. Cholesterol oxidation in-
volves several mono-oxygenation reactions, which are catalyzed by
cytochromes P450 (CYPs). During normal hepatic cholesterol de-
gradation, it can be enzymatically converted to 7α-hydroxycholestrol
by 7α-hydroxylase. Other CYPs such as 27-hydroxylase and 4β-hydro-
xylase catalyze the formation of the mayor oxysterol species 27-hy-
droxycholesterol and 4β-hydroxycholestrol, respectively. Alternatively,
cholesterol can be metabolized by non-enzymatic autoxidation, which
leads to the formation of 7-ketocholesterol, 7α-hydroxycholesterol, 7β-
hydroxycholesterol, 5,6α-epoxycholesterol and 5,6β-epoxycholesterol.
There is increasing interest in the biological activity of oxysterols, not
Fig. 4. Co-treating primary hepatocytes with
fatty acids and the oxysterol triol induces cell
death. (A) Cell viability of rat primary hepatocytes
after 24 incubation with palmitic acid (PA)±oleic
acid (OA)±Triol, assessed by the MTT assay. Data
are expressed as mean±SDM of three consecutive
experiments. Statistical differences were assessed by
one-way ANOVA and Tukey-Kramer as post-hoc test.
(B) Effect of 24 h incubation with Triol 10 µM, pal-
mitic acid 50 µM + oleic acid 2 mM (PA+OA), or
palmitic acid 50 µM + oleic acid 2 mM + Triol
10 µM (PA + OA + Triol) on rat primary hepato-
cytes aptoptosis and necrosis. Apoptotic or necrotic
cells were detected by flow cytometry after staining
with annexin V and 7-AAD. 50 µM PA and 2 mM OA
were chosen as the highes non-toxic concentrations
for the induction of cellular steatosis.
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Fig. 5. Mitochondrial function and biogenesis impairment in primary hepatocytes after co-treatment with fatty acids and the oxysterol triol. (A) Oxygen consumption rate of isolated liver
mitochondria after incubation with increased concentrations of 5α-cholestane-3β,5,6β-triol (Triol) for 24 h. Mitochondrial respiration was started by pyruvate+malate and glutamate
(Complex I) or succinate in the presence of rotenone (Complex II). Data are expressed as mean± SDM of three consecutive experiments. Statistical differences were assessed by one-way
ANOVA and Tukey-Kramer as post-hoc test (* = p<0.05 vs CTRL, ** = p<0.01 vs CTRL). (B) Representative oxygraphic measurement of intact hepatocytes respiration after 24 h
incubation with palmitic acid (PA) + oleic acid (OA)±Triol. (C) Mitochondrial/cellular respiratory rate measured in intact rat primary hepatocytes after 24 h incubation with
PA+OA±Triol. (D) Gene expression of peroxisome proliferator-activated receptor-γ coactivator 1 α (PGC1α), mitochondrial transcription factor A (TFAM) and nuclear respiratory
factor 1 (NRF1) measured by real time rt-PCR in the rat primary hepatocytes after 24 h incubation with PA+OA±Triol. Data are expressed as mean± SDM of three consecutive
experiments. Statistical differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test.
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only because they are non-invasive markers of oxidative stress in vivo
[33], but also because they may be part of the fine signaling controlling
hepatocyte survival in several conditions [34].
We have previously demonstrated that steatohepatitis induced by
dietary excess of both fatty acids and cholesterol is associated with a
definite oxysterol pattern [14]. In the present study, we have focused
on the non-enzymatic oxysterols since the hepatic expression of several
enzymes involved in oxysterol generation is reduced in human NASH
Fig. 6. Reduction of mitochondrial respiratory proteins and master regulators of biogenesis in human NASH. (A) Representative second dimension of a BN-PAGE performed on
mitochondrial proteins isolated by the liver of healthy subjects (HEALTHY) and patients affected by simple steatosis (NAFL) or steatohepatitis (NASH). Bands characteristic of individual
OXPHOS complexes are recognizable in all three experimental groups. Protein extracts were prepared for each patient, and each individual was assessed separately. Each lane contained
15 μg of mitochondrial protein extract. (B) Gene expression of peroxisome proliferator-activated receptor-γ coactivator 1 α (PGC1α), mitochondrial transcription factor A (TFAM) and
nuclear respiratory factor 1 (NRF1) measured by real time rt-PCR in the liver of all patient groups studied. Data are expressed as mean± SDM of 8+7+10 experiments. Statistical
differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test.
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[35], and some of enzymatic oxysterols may be even protective, by
counteracting the hepatic lipid accumulation and inflammation
[36–38]. The intake of oxysterols produced by autoxidation sig-
nificantly accelerates the development of NAFLD in primates [39]. We
show that rats feeding a diet with high fat and high cholesterol develop
steatohepatitis and the liver is characterized by high concentrations of
non-enzymatic oxysterols such as 7β-hydroxycholesterol (7β-OHC), 7-
ketocholesterol (7KC) and triol. This model of liver disease associates
with all hallmarks of mitochondrial dysfunction, i.e. altered respiration,
increased H2O2 production, uncoupling and impaired ATP homeostasis.
Several in vitro studies demonstrated that 7β-OHC, 7KC and triol are
able to induce mitochondrial dysfunction and mitochondria-dependent
apoptosis [40–42]. We observed that such oxysterols do not affect cell
viability because hepatocytes rapidly metabolize 7KC, the major dietary
oxysterol [43,44]. However, triol significantly impaired mitochondrial
respiration. Very interestingly, the addition of triol to free fatty acids
reduces hepatocytes viability by impairing mitochondrial respiration.
Our data show, for the first time, that NASH induced by dietary fatty
acid and cholesterol excess associates with mitochondrial dysfunction.
Furthermore, when hepatocytes are cultured with a mixture of fatty
acids and oxysterols, both mitochondrial respiration and cell viability
decrease, suggesting a possible synergic interaction between different
lipid species in the pathogenesis of liver cell damage.
A large body of evidence indicates that high-fat diets induce adap-
tive mechanisms in mitochondrial bioenergetics, such as increased
electron transport chain performance and uncoupling [23,45]. On the
other side, high-cholesterol diet increases liver mitochondria respira-
tion, uncoupling and induces expression of genes involved in mi-
tochondrial biogenesis [46].
Our data show that combination of HF and HCh diets induce mi-
tochondria dysfunction, alters energy homeostasis and limits the
adaptive response to energy demand by impairing mitochondria bio-
genesis. These finding are strengthened by the bi-dimensional analysis
of mitochondrial respiration chain content in human liver, demon-
strating that proteins of the Complex I, IV and V are reduced in non-
alcoholic steatohepatitis but not in simple steatosis. Moreover, mi-
tochondrial biogenesis response is impaired at the level of PGC-1α,
NRF1, and TFAM, which are involved in mtDNA transcription, main-
tenance, replication and repair [47] in good agreement with previous
observations reporting that altered mitochondrial function in human
NASH is dependent by defective mitochondrial biogenesis [48].
In conclusion, high-fat diet causes simple steatosis and mild liver
injury that do not overwhelm defense response of the liver; on the
contrast, the combination of FFAs and cholesterol induces severe in-
flammation and steatohepatitis and, at cellular level, impairment of
mitochondrial function and biogenesis. The pathogenic contribution of
cholesterol depends on oxysterols production that are able to disrupt
mitochondrial homeostasis, reduce mitochondrial function and energy
production and impair the capacity of repair by inhibiting mitochon-
drial biogenesis. Oxysterols may represent a potential target of novel
therapeutic strategy in NAFLD progression.
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